CA Stock MarketDetailed Quotes

MindBio Therapeutics Corp (MBIO)

Watchlist
  • 1.220
  • -0.220-15.28%
15min DelayMarket Closed May 1 15:46 ET
5.85MMarket Cap-0.37P/E (TTM)

MindBio Therapeutics Corp (MBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
-630.65K
433.23K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
---630.65K
--433.23K
Cost of revenue
Gross profit
Operating expense
1,032.76%2.41M
1,480.39%1.21M
3,347.82%1.93M
234.36%749.66K
243.88%889.89K
10.81%213.18K
-53.14%76.4K
-98.23%55.95K
-120.93%-557.95K
14.77%258.78K
Selling and administrative expenses
1,848.02%2.3M
2,612.61%1.18M
199.56%1.9M
998.47%1.61M
-52.50%99.88K
-4.60%117.93K
-58.70%43.42K
-80.31%634.08K
-94.75%146.73K
4.19%210.25K
-Selling and marketing expense
2,509.83%162.23K
58.07%6.27K
-55.97%26.67K
119.27%14.44K
-89.11%2.06K
-62.84%6.22K
-78.43%3.97K
-79.31%60.57K
-93.81%6.59K
-84.78%18.87K
-General and administrative expense
1,811.19%2.14M
2,869.40%1.17M
226.55%1.87M
1,039.78%1.6M
-48.88%97.83K
4.52%111.71K
-54.52%39.46K
-80.41%573.51K
-94.78%140.14K
145.88%191.38K
Research and development costs
--103.81K
----
----
----
----
----
----
----
----
----
Depreciation amortization depletion
----
--273
----
----
--0
83.15%88.65K
----
----
----
70.01%40.25K
-Depreciation and amortization
----
--273
----
----
--0
83.15%88.65K
----
----
----
70.01%40.25K
Other operating expenses
107.00%13.66K
-11.01%29.35K
105.13%29.64K
-25.55%-773.44K
9,440.04%790.01K
-67.61%6.6K
-43.05%32.98K
-956.08%-578.13K
---616.02K
--8.28K
Operating profit
-1,032.76%-2.41M
-1,480.39%-1.21M
-3,347.82%-1.93M
-931.10%-749.66K
-610.12%-889.89K
-4,328.82%-213.18K
53.14%-76.4K
98.23%-55.95K
97.27%-72.71K
177.37%174.45K
Net non-operating interest income (expenses)
99.68%-529
-64.07%-581.39K
-62.49%-263.9K
-48.25%-83.72K
-106.73%-163.86K
-24.37%-69.91K
21.48%-354.35K
33.24%-162.41K
17.96%-56.47K
Non-operating interest expense
-99.68%529
----
64.07%581.39K
62.49%263.9K
48.25%83.72K
106.73%163.86K
24.37%69.91K
-21.48%354.35K
-33.24%162.41K
-17.96%56.47K
Other net income (expenses)
-42,886.38%-296.61K
-1,619.68%-426.57K
177.20%31.78K
-119.29%-6.58K
224.11%101.03K
99.90%-690
94.93%-24.81K
-548.24%-41.16K
Gain on sale of security
----
----
----
----
177.20%31.78K
-119.29%-6.58K
224.11%101.03K
95.31%-14.89K
90.73%-39.01K
-548.24%-41.16K
Special income (charges)
----
----
-199.78%-320.24K
----
----
----
----
1,222.03%320.95K
----
----
-Less:Impairment of capital assets
----
----
--587.75K
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
16.65%-267.51K
----
----
----
----
-1,222.03%-320.95K
----
----
Other non-operating income (expenses)
----
----
107.70%23.63K
----
----
----
----
18.14%-306.75K
----
----
Income before tax
-529.62%-2.42M
-2,566.44%-1.21M
-583.01%-2.81M
-454.07%-1.44M
-1,326.10%-941.84K
-856.19%-383.61K
75.92%-45.28K
90.41%-411K
92.36%-259.92K
125.55%76.82K
Income tax
0
0
0
0
Earnings from equity interest net of tax
Net income
-529.62%-2.42M
-2,566.44%-1.21M
-583.01%-2.81M
-454.07%-1.44M
-1,326.10%-941.84K
-856.19%-383.61K
75.92%-45.28K
90.41%-411K
92.36%-259.92K
125.55%76.82K
Net income continuous operations
-529.62%-2.42M
-2,566.44%-1.21M
-583.01%-2.81M
-454.07%-1.44M
-1,326.10%-941.84K
-856.19%-383.61K
75.92%-45.28K
90.41%-411K
92.36%-259.92K
125.55%76.82K
Noncontrolling interests
118.49%791
-5.94%507
-4.28K
272.76%539
Net income attributable to the company
-536.92%-2.42M
-2,536.18%-1.21M
-583.01%-2.81M
-454.07%-1.44M
-1,326.10%-941.84K
-845.53%-379.34K
75.60%-45.82K
90.41%-411K
92.36%-259.92K
125.55%76.82K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-536.92%-2.42M
-2,536.18%-1.21M
-583.01%-2.81M
-454.07%-1.44M
-1,326.10%-941.84K
-845.53%-379.34K
75.60%-45.82K
90.41%-411K
92.36%-259.92K
125.55%76.82K
Diluted earnings per share
52.52%-0.504
0
-150.00%-4
-31.75%-1.0143
-1,016.67%-2.117
-779.98%-1.0614
0
90.00%-1.6
92.47%-0.7699
125.55%0.2309
Basic earnings per share
52.52%-0.504
0
-150.00%-4
-31.75%-1.0143
-1,016.67%-2.117
-779.98%-1.0614
0
90.00%-1.6
92.47%-0.7699
125.55%0.2309
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 00000000-630.65K433.23K
Operating revenue --0--0--0--0--0--0--0--0---630.65K--433.23K
Cost of revenue
Gross profit
Operating expense 1,032.76%2.41M1,480.39%1.21M3,347.82%1.93M234.36%749.66K243.88%889.89K10.81%213.18K-53.14%76.4K-98.23%55.95K-120.93%-557.95K14.77%258.78K
Selling and administrative expenses 1,848.02%2.3M2,612.61%1.18M199.56%1.9M998.47%1.61M-52.50%99.88K-4.60%117.93K-58.70%43.42K-80.31%634.08K-94.75%146.73K4.19%210.25K
-Selling and marketing expense 2,509.83%162.23K58.07%6.27K-55.97%26.67K119.27%14.44K-89.11%2.06K-62.84%6.22K-78.43%3.97K-79.31%60.57K-93.81%6.59K-84.78%18.87K
-General and administrative expense 1,811.19%2.14M2,869.40%1.17M226.55%1.87M1,039.78%1.6M-48.88%97.83K4.52%111.71K-54.52%39.46K-80.41%573.51K-94.78%140.14K145.88%191.38K
Research and development costs --103.81K------------------------------------
Depreciation amortization depletion ------273----------083.15%88.65K------------70.01%40.25K
-Depreciation and amortization ------273----------083.15%88.65K------------70.01%40.25K
Other operating expenses 107.00%13.66K-11.01%29.35K105.13%29.64K-25.55%-773.44K9,440.04%790.01K-67.61%6.6K-43.05%32.98K-956.08%-578.13K---616.02K--8.28K
Operating profit -1,032.76%-2.41M-1,480.39%-1.21M-3,347.82%-1.93M-931.10%-749.66K-610.12%-889.89K-4,328.82%-213.18K53.14%-76.4K98.23%-55.95K97.27%-72.71K177.37%174.45K
Net non-operating interest income (expenses) 99.68%-529-64.07%-581.39K-62.49%-263.9K-48.25%-83.72K-106.73%-163.86K-24.37%-69.91K21.48%-354.35K33.24%-162.41K17.96%-56.47K
Non-operating interest expense -99.68%529----64.07%581.39K62.49%263.9K48.25%83.72K106.73%163.86K24.37%69.91K-21.48%354.35K-33.24%162.41K-17.96%56.47K
Other net income (expenses) -42,886.38%-296.61K-1,619.68%-426.57K177.20%31.78K-119.29%-6.58K224.11%101.03K99.90%-69094.93%-24.81K-548.24%-41.16K
Gain on sale of security ----------------177.20%31.78K-119.29%-6.58K224.11%101.03K95.31%-14.89K90.73%-39.01K-548.24%-41.16K
Special income (charges) ---------199.78%-320.24K----------------1,222.03%320.95K--------
-Less:Impairment of capital assets ----------587.75K------------------0--------
-Less:Other special charges --------16.65%-267.51K-----------------1,222.03%-320.95K--------
Other non-operating income (expenses) --------107.70%23.63K----------------18.14%-306.75K--------
Income before tax -529.62%-2.42M-2,566.44%-1.21M-583.01%-2.81M-454.07%-1.44M-1,326.10%-941.84K-856.19%-383.61K75.92%-45.28K90.41%-411K92.36%-259.92K125.55%76.82K
Income tax 0000
Earnings from equity interest net of tax
Net income -529.62%-2.42M-2,566.44%-1.21M-583.01%-2.81M-454.07%-1.44M-1,326.10%-941.84K-856.19%-383.61K75.92%-45.28K90.41%-411K92.36%-259.92K125.55%76.82K
Net income continuous operations -529.62%-2.42M-2,566.44%-1.21M-583.01%-2.81M-454.07%-1.44M-1,326.10%-941.84K-856.19%-383.61K75.92%-45.28K90.41%-411K92.36%-259.92K125.55%76.82K
Noncontrolling interests 118.49%791-5.94%507-4.28K272.76%539
Net income attributable to the company -536.92%-2.42M-2,536.18%-1.21M-583.01%-2.81M-454.07%-1.44M-1,326.10%-941.84K-845.53%-379.34K75.60%-45.82K90.41%-411K92.36%-259.92K125.55%76.82K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -536.92%-2.42M-2,536.18%-1.21M-583.01%-2.81M-454.07%-1.44M-1,326.10%-941.84K-845.53%-379.34K75.60%-45.82K90.41%-411K92.36%-259.92K125.55%76.82K
Diluted earnings per share 52.52%-0.5040-150.00%-4-31.75%-1.0143-1,016.67%-2.117-779.98%-1.0614090.00%-1.692.47%-0.7699125.55%0.2309
Basic earnings per share 52.52%-0.5040-150.00%-4-31.75%-1.0143-1,016.67%-2.117-779.98%-1.0614090.00%-1.692.47%-0.7699125.55%0.2309
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More